Methimazole in Patients With Progressive Glioblastoma

Clinical trial NCT05607407 · SUSPENDED

Trial details

NCT number: NCT05607407
Sponsor: Case Comprehensive Cancer Center
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Glioma

Start date: 2023-01-30
Primary completion: 2026-09-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.